WallStreetZenWallStreetZen

NASDAQ: SCLX
Scilex Holding Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SCLX

Based on 2 analysts offering 12 month price targets for Scilex Holding Co.
Min Forecast
$7.00+573.08%
Avg Forecast
$10.00+861.54%
Max Forecast
$13.00+1,150%

Should I buy or sell SCLX stock?

Based on 2 analysts offering ratings for Scilex Holding Co.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SCLX stock forecasts and price targets.

SCLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-17
lockedlocked$00.00+00.00%2024-06-13

1 of 1

Forecast return on equity

Is SCLX forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is SCLX forecast to generate an efficient return on assets?
Company
-81.64%
Industry
22.33%
SCLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SCLX earnings per share forecast

What is SCLX's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.79
Avg 2 year Forecast
-$0.45
Avg 3 year Forecast
-$0.45

SCLX revenue forecast

What is SCLX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$65.4M+28.72%
Avg 2 year Forecast
$96.5M+89.75%
Avg 3 year Forecast
$100.1M+96.96%
SCLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCLX revenue growth forecast

How is SCLX forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
31.6%
Industry
9.59%
Market
8.17%
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCLX vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
SCLX$1.04$10.00+861.54%Strong Buy
AMRN$0.60N/AN/A
MIRA$1.55$11.00+609.68%Buy
OGN$20.49$21.33+4.11%Hold
GRFS$8.49N/AN/A
View Top General Drug Manufacturer Stocks

Scilex Holding Co Stock Forecast FAQ

Is Scilex Holding Co Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SCLX) stock is to Strong Buy SCLX stock.

Out of 2 analysts, 1 (50%) are recommending SCLX as a Strong Buy, 1 (50%) are recommending SCLX as a Buy, 0 (0%) are recommending SCLX as a Hold, 0 (0%) are recommending SCLX as a Sell, and 0 (0%) are recommending SCLX as a Strong Sell.

If you're new to stock investing, here's how to buy Scilex Holding Co stock.

What is SCLX's earnings growth forecast for 2024-2026?

(NASDAQ: SCLX) Scilex Holding Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 49.27%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.32%.

Scilex Holding Co's earnings in 2024 is -$118,888,000.On average, 3 Wall Street analysts forecast SCLX's earnings for 2024 to be -$150,881,602, with the lowest SCLX earnings forecast at -$228,230,719, and the highest SCLX earnings forecast at -$95,895,260. On average, 3 Wall Street analysts forecast SCLX's earnings for 2025 to be -$85,672,825, with the lowest SCLX earnings forecast at -$128,499,648, and the highest SCLX earnings forecast at -$47,947,630.

In 2026, SCLX is forecast to generate -$85,346,781 in earnings, with the lowest earnings forecast at -$120,828,028 and the highest earnings forecast at -$49,865,535.

What is SCLX's revenue growth forecast for 2024-2026?

(NASDAQ: SCLX) Scilex Holding Co's forecast annual revenue growth rate of 31.6% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.17%.

Scilex Holding Co's revenue in 2024 is $50,833,000.On average, 3 Wall Street analysts forecast SCLX's revenue for 2024 to be $12,549,429,095, with the lowest SCLX revenue forecast at $11,814,296,032, and the highest SCLX revenue forecast at $13,885,633,648. On average, 3 Wall Street analysts forecast SCLX's revenue for 2025 to be $18,499,346,397, with the lowest SCLX revenue forecast at $13,323,687,424, and the highest SCLX revenue forecast at $26,045,152,616.

In 2026, SCLX is forecast to generate $19,202,066,862 in revenue, with the lowest revenue forecast at $13,989,200,529 and the highest revenue forecast at $24,414,933,196.

What is SCLX's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: SCLX) forecast ROA is -81.64%, which is lower than the forecast US Drug Manufacturers - General industry average of 22.33%.

What is SCLX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SCLX price target, the average SCLX price target is $10.00, with the highest SCLX stock price forecast at $13.00 and the lowest SCLX stock price forecast at $7.00.

On average, Wall Street analysts predict that Scilex Holding Co's share price could reach $10.00 by Jun 17, 2025. The average Scilex Holding Co stock price prediction forecasts a potential upside of 861.54% from the current SCLX share price of $1.04.

What is SCLX's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: SCLX) Scilex Holding Co's current Earnings Per Share (EPS) is -$1.43. On average, analysts forecast that SCLX's EPS will be -$0.79 for 2024, with the lowest EPS forecast at -$1.19, and the highest EPS forecast at -$0.50. On average, analysts forecast that SCLX's EPS will be -$0.45 for 2025, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.25. In 2026, SCLX's EPS is forecast to hit -$0.45 (min: -$0.63, max: -$0.26).

What is SCLX's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: SCLX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.